- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 11 residues within 4Å:- Chain A: S.620, S.623, A.624, N.627, Q.729
- Chain B: E.98, L.99, H.101, E.265, Y.266, R.343
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.343, B:R.343, B:E.98, B:E.98, B:L.99
- Water bridges: B:H.101, B:R.343
NAG-NAG-BMA-MAN-MAN.18: 11 residues within 4Å:- Chain A: E.98, L.99, H.101, E.265, Y.266, R.343
- Chain B: S.620, S.623, A.624, N.627, Q.729
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.343, A:R.343, A:E.98, A:E.98, A:L.99
- Water bridges: A:H.101, A:R.343
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 6 residues within 4Å:- Chain A: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.9
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.366, A:D.376, A:D.442, A:D.442, H2O.1
ZN.9: 5 residues within 4Å:- Chain A: D.376, E.414, H.542
- Ligands: ZN.8, JB7.12
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.376, A:E.414, A:E.414, A:H.542, H2O.1
ZN.20: 6 residues within 4Å:- Chain B: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.21
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.366, B:D.376, B:D.442, B:D.442, H2O.24
ZN.21: 5 residues within 4Å:- Chain B: D.376, E.414, H.542
- Ligands: ZN.20, JB7.24
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.376, B:E.414, B:E.414, B:H.542, H2O.24
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
CA.11: 4 residues within 4Å:- Chain A: T.258, Y.261, E.422, E.425
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:T.258, A:E.422, A:E.422, A:E.425, H2O.1
CA.23: 4 residues within 4Å:- Chain B: T.258, Y.261, E.422, E.425
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.258, B:E.422, B:E.422, B:E.425, H2O.24
- 2 x JB7: N-({(1S)-5-[acetyl(4-bromobenzyl)amino]-1-carboxypentyl}carbamoyl)-L-glutamic acid(Non-covalent)
JB7.12: 23 residues within 4Å:- Chain A: G.195, K.196, R.199, N.246, D.376, E.413, E.414, G.416, L.417, G.507, N.508, R.523, R.525, F.535, S.536, G.537, Y.541, H.542, N.687, K.688, Y.689, A.690
- Ligands: ZN.9
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:Y.541, A:Y.689, A:Y.689, A:Y.689
- Hydrogen bonds: A:N.246, A:N.246, A:E.414, A:G.507, A:G.507, A:G.507, A:G.507, A:N.508, A:Y.541, A:Y.689
- Water bridges: A:Q.243, A:N.246, A:R.523, A:K.688
- Salt bridges: A:R.199, A:R.523, A:R.525, A:H.542, A:K.688
JB7.24: 23 residues within 4Å:- Chain B: G.195, K.196, R.199, N.246, D.376, E.413, E.414, G.416, L.417, G.507, N.508, R.523, R.525, F.535, S.536, G.537, Y.541, H.542, N.687, K.688, Y.689, A.690
- Ligands: ZN.21
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:Y.541, B:Y.689, B:Y.689, B:Y.689
- Hydrogen bonds: B:N.246, B:N.246, B:E.414, B:G.507, B:G.507, B:G.507, B:G.507, B:N.508, B:Y.541, B:Y.689
- Water bridges: B:Q.243, B:N.246, B:R.523, B:K.688
- Salt bridges: B:R.199, B:R.523, B:R.525, B:H.542, B:K.688
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x JB7: N-({(1S)-5-[acetyl(4-bromobenzyl)amino]-1-carboxypentyl}carbamoyl)-L-glutamic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A